Export Full Drugs Database Catalog
EGYPTIAN PHARMACEUTICAL DIRECTORY
FLAMOFENAC 0.09% EYE DROPS 5 ML
OFFICIAL RETAIL PRICE
EGP 40.00
Active Molecule
BROMFENAC
Form & Route
Eye
Manufacturer
GLOBAL ADVANCED PHARMACEUTICALS (GAP) > MONOPHARMA PHARMACEUTICALS
Therapeutic Class
NSAID
Commercial brands in Egypt sharing the exact same active molecule & dosage form.
Eye
•
EVA PHARMA
EGP 40.00
Same Price
Eye
•
ORCHIDIA PHARMACEUTICAL INDUSTRIES > ELW PHARMA
EGP 52.50
+EGP 12.50
Commercial brands in NSAID that achieve equivalent therapeutic outcomes.
IBUPROFEN + PARACETAMOL (ACETAMINOPHEN)
Oral Liquid (Syrup / Suspension)
•
KAHIRA
EGP 5.00
Saves EGP 35.00
IBUPROFEN + PARACETAMOL (ACETAMINOPHEN)
Oral Liquid (Syrup / Suspension)
•
KAHIRA
EGP 6.75
Saves EGP 33.25
EGP 140.00
+EGP 100.00
EGP 120.00
+EGP 80.00
ACETYLSALICYLIC ACID + CAFFEINE
Oral Solid (Tablets / Capsules)
•
ALEXANDRIA
EGP 1.05
Saves EGP 38.95
ACETYLSALICYLIC ACID + CAFFEINE + PARACETAMOL (ACETAMINOPHEN)
Oral Solid (Tablets / Capsules)
•
CHEMIPHARM
EGP 8.25
Saves EGP 31.75
CAFFEINE + PARACETAMOL (ACETAMINOPHEN)
Oral Solid (Tablets / Capsules)
•
JEDCO INT. CO. FOR PHARMACEUTICALS
EGP 5.00
Saves EGP 35.00
KETOROLAC TROMETHAMINE
Oral Solid (Tablets / Capsules)
•
ARAB DRUG COMPANY (ADCO)
EGP 15.00
Saves EGP 25.00
ACETYLSALICYLIC ACID + CAFFEINE + PARACETAMOL (ACETAMINOPHEN)
Oral Solid (Tablets / Capsules)
•
DELTA PHARMA
EGP 5.50
Saves EGP 34.50
EGP 40.00
Same Price
EGP 60.00
+EGP 20.00
EGP 7.00
Saves EGP 33.00
EGP 45.00
+EGP 5.00
EGP 26.00
Saves EGP 14.00
EGP 44.00
+EGP 4.00
IBUPROFEN + PARACETAMOL (ACETAMINOPHEN)
Oral Solid (Tablets / Capsules)
•
UNIPHARMA
EGP 69.00
+EGP 29.00
EGP 27.75
Saves EGP 12.25
EGP 26.40
Saves EGP 13.60
EGP 26.40
Saves EGP 13.60
EGP 28.00
Saves EGP 12.00
NEPAFENAC
Eye
•
DELTA GRAND PHARMA > MARCYRL PHARMACEUTICAL INDUSTRIES (MPI)
EGP 18.60
Saves EGP 21.40
Verified Directory Notice: Official retail pricing and commercial specifications reflect Egyptian MOH/EDA registered records. Always consult a licensed healthcare professional or pharmacist prior to modifying or substituting prescription drug treatments.